Real-World data reveals how bosutinib fights leukemia outside clinical trials
NCT ID NCT05363488
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study looks back at medical records from a single hospital in Scotland to see how well the drug bosutinib works and how safe it is for people with chronic myeloid leukemia (CML) in everyday practice. Researchers will track blood cell counts, genetic responses, and side effects in 17 patients who took bosutinib as part of their normal care. The goal is to understand the drug's real-world effectiveness beyond the controlled conditions of clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bosutinib
- What this could lead to
- If successful, this study could provide a clearer picture of how bosutinib performs outside of controlled trials, helping doctors make better treatment decisions for people with chronic myeloid leukemia.
- What could go wrong
- This is a small, retrospective study at a single center, so results may not apply to all patients. It only describes what happened in the past, not a controlled experiment, so it cannot prove cause and effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Eatson West of Scotland Cancer Center
Glasgow, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Can a smart tool keep watch on leukemia after treatment stops?
- Can donor immune cells tame stem cell transplant risks?
- Can a gentler chemo-radiation combo make stem cell transplants safer for blood cancers?
- Could bone marrow from deceased donors cure blood cancers?
- New hope for young adults with CML: asciminib under Real-World scrutiny